The Illinois General Assembly offers the Google Translate™ service for visitor convenience. In no way should it be considered accurate as to the translation of any content herein.
Visitors of the Illinois General Assembly website are encouraged to use other translation services available on the internet.
The English language version is always the official and authoritative version of this website.
NOTE: To return to the original English language version, select the "Show Original" button on the Google Translate™ menu bar at the top of the window.
Synopsis As Introduced Amends the Prior Authorization Reform Act and the Illinois Public Aid Code. Provides that a health insurance issuer, the fee-for-service medical assistance program, and a Medicaid managed care organization may not require prior authorization for the following prescription drug types and their therapeutic equivalents approved by the United States Food and Drug Administration: human immunodeficiency virus pre-exposure prophylaxis and post-exposure prophylaxis medication or human immunodeficiency virus treatment medication. Effective January 1, 2027.
Replaces everything after the enacting clause with the provisions of the introduced bill with the following changes. Amends the Illinois Public Aid Code. In provisions concerning utilization controls, removes provisions concerning drugs for the treatment of HIV or AIDS. Amends the Illinois Insurance Code to include pre-PrEP HIV screening, sexually transmitted infection screening, kidney function analysis, routine laboratory testing, and routine provider visits as covered follow-up services in provisions requiring an individual or group policy of accident and health insurance to provide coverage for all abortifacients, hormonal therapy medication, human immunodeficiency virus pre-exposure prophylaxis, and post-exposure prophylaxis drugs approved by the United States Food and Drug Administration, and follow-up services related to that coverage. Effective on January 1, 2027.
Judicial Note (Admin Office of the Illinois Courts)
Based on a review of HB2584, as amended by House Amendment 1, the legislation will not increase or decrease the number of judges needed in the state of Illinois.
Balanced Budget Note (Office of Management and Budget)
Please be advised that the Balanced Budget Note Act does not apply to House Bill 2584, as amended by House Amendment 1 as it is not a supplemental appropriation that increases or decreases appropriations. Under the Act, a balanced budget note must be prepared only for bills that change a general funds appropriation for the fiscal year in which the new bill is enacted.
Housing Affordability Impact Note (Housing Development Authority)
This bill will have no effect on the cost of constructing, purchasing, owning, or selling a single-family residence.
HB 2584, as amended by HA 1, will not impact any public pension fund or retirement system in the State of Illinois.
State Debt Impact Note (Government Forecasting & Accountability)
HB 2584, House Amendment 1, would not change the amount of authorization for any type of State-issued bond, and, therefore, would not affect the level of State indebtedness.
Fiscal Note (Dept. of Healthcare & Family Services)
HB2584 has an estimated annualized cost to the Illinois Medical Assistance Program of $48.8 million due to a total loss of supplemental rebate revenue for the Illinois Department of Healthcare and Family Services and utilization shifts to higher-cost medications. The majority of this annual cost is due to the loss of supplemental rebate revenue.
Racial Impact Note (Dept. of Healthcare & Family Services)
Changes to the Public Aid Code proposed in House Bill 2584, as amended by House Amendment # 1, would impact approximately 18,000 Medicaid customers currently utilizing the medications as described. A total of 62% of current Medicaid customers utilizing these medications self-report as racial or ethnic minorities. This is higher than 35% of the entire population of Medicaid customers who identify as racial or ethnic minorities. The trend over the last 3 years is mostly steady for Medicaid customers identifying as racial or ethnic minorities who utilize the medications. The procedural changes proposed by HA #1 would impact all Medicaid customers utilizing or who may utilize these medications in the future.
Replaces everything after the enacting clause with the provisions of bill, as amended by House Amendment No. 1, with the following change: Removes provisions amending the Illinois Public Aid Code. Effective on January 1, 2027.
This site is maintained for the Illinois General Assembly
by the Legislative Information System, 705 Stratton Building, Springfield, Illinois 62706
Contact ILGA Webmaster